Peripheral Artery Disease Treatment: Paclitaxel & Sirolimus | VER Journal
Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial | Circulation: Cardiovascular Interventions
Drug eluting balloons for treatment of femoropopliteal disease
Drug-eluting balloon: design, technology and clinical aspects
Lutonix™ 035 Drug Coated Balloon PTA Catheter
CR Bard LUTONIX 035 Drug-Coated Balloon PTA Catheter - LUTONIX 035 Dru — Grayline Medical
LX351307605F Lutonix 035 Drug Coated Balloon PTA Catheter 5F - MedicalEcart
New BARD LX35757405F Lutonix 035 Drug Coated Balloon PTA Catheter, 75cm (X) Disposables - General For Sale - DOTmed Listing #3494356:
Bard LX351305100 Lutonix 035 Drug Coated Balloon PTA Catheter - MedicalEcart
An Experimental Study of Paclitaxel Embolisation During Drug Coated Balloon Angioplasty - ScienceDirect
INVAMED Research & Development | EXTENDER PTCA Drug Released Coronary Balloon
Lutonix: Drug Coated Balloons (DCB) for Angioplasties - Lutonix
U.S. Drug-Coated Balloons Market Threatened by Reimbursement Cuts and | mddionline.com
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
Medtronic and C.R. Bard Battle for Leading Position in 2018 US Drug-Coated Balloons Market - iData Research
Lutonix registry data confirm durability of drug-coated balloon treatment in superficial femoral artery disease - Interventional News
Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease | JACC: Cardiovascular Interventions
12mm x 60mm - 75 cm long Lutonix™ AV Drug Coated Balloon - LX35751260V | BD
Bard's Drug-Coated Angioplasty Balloon Continues to Show Efficacy | mddionline.com
Bard | Lutonix Drug Coated Balloon
Drug-coated balloons: Technical and clinical progress - Huiying Ang, Tobias R Koppara, Salvatore Cassese, Jaryl Ng, Michael Joner, Nicolas Foin, 2020
Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
Materials technology in drug eluting balloons: Current and future perspectives - ScienceDirect
C. R. Bard Receives FDA Premarket Approval For The LUTONIX 035 Drug Coated Balloon - Medical Design and Outsourcing
Materials technology in drug eluting balloons: Current and future perspectives - ScienceDirect
Boston Scientific to Distribute Bard's Lutonix Drug-eluting Balloon | DAIC
Drug-Coated Balloons Expand Treatment Options
